You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Drug Price Trends for NDC 00703-7133


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00703-7133

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
HALOPERIDOL DECANOATE 100MG/ML INJ AvKare, LLC 00703-7133-01 5ML 71.35 14.27000 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 00703-7133

Understanding the NDC

The National Drug Code (NDC) is a unique identifier assigned to each drug product, including the labeler, product, and package size. For the NDC 00703-7133, it is crucial to identify the associated drug to conduct a thorough market analysis and price projection[1][4].

Identifying the Drug

To start, you need to identify the drug associated with the NDC 00703-7133. This can be done by referencing the FDA's National Drug Code Directory or similar resources. Once the drug is identified, you can proceed to analyze its therapeutic area, market trends, and competitive landscape.

Therapeutic Area and Market Trends

Understanding the therapeutic area in which the drug operates is vital. Different therapeutic areas have distinct market dynamics, regulatory environments, and competitive landscapes. For example, if the drug falls under a highly competitive area like oncology or immunology, it would be subject to different market pressures compared to a less competitive area like rare diseases[3][4].

Competitive Landscape

Analyzing the competitive landscape involves identifying branded and generic alternatives, as well as any new entrants or combination therapies that could impact the pricing of the drug. The entry of generics, for instance, can significantly reduce prices by 50% to 70% as seen in markets like Non-Small Cell Lung Cancer (NSCLC)[4].

Regulatory Environment

Regulatory changes can significantly impact drug pricing. For example, the Drug Supply Chain Security Act and revisions to establishment registration and drug listing requirements can affect how drugs are tracked and priced. Any recent or upcoming regulatory changes should be considered when projecting prices[4].

Technological Advancements

Technological advancements, particularly in clinical trial designs and the use of AI and machine learning, can lead to more efficient drug development and potentially reduce costs. This could influence pricing by making the drug more competitive or by reducing development costs that are often passed on to consumers[3].

Historical Pricing Data

Reviewing historical pricing data for similar drugs in the same therapeutic area can provide insights into potential future price trends. This includes looking at price inflation, market competition, and any significant events that have impacted pricing in the past[2][4].

Price Projections

Current Pricing

If the drug associated with NDC 00703-7133 is a premium-priced medication, its current pricing could be substantial, similar to other drugs in its therapeutic area. For example, in the NSCLC market, immunotherapies can range from $100,000 to $200,000 per year[4].

Future Projections

Several factors can influence future price projections:

  • Entry of Generics: If a generic version of the drug becomes available, prices could drop significantly, typically by 50% to 70%.
  • New Combination Therapies: The introduction of new combination therapies could increase competition, potentially reducing prices.
  • Regulatory Changes: Changes in regulatory frameworks could affect pricing by altering how drugs are tracked, listed, and reimbursed.
  • Technological Advancements: Innovations in drug development could reduce costs and influence pricing.

Example Scenario

For illustrative purposes, let's assume the drug associated with NDC 00703-7133 is a premium-priced immunotherapy in a competitive therapeutic area.

  • Current Pricing: The drug could be priced around $150,000 per year.
  • Future Projections: If a generic version becomes available, the price could drop to $45,000 to $75,000 per year. If new combination therapies enter the market, prices might decrease further due to increased competition.

Key Takeaways

  • NDC Importance: The NDC is crucial for tracking and managing drugs in the healthcare system.
  • Market Trends: The biopharma and biotech industries are driven by technological advancements and evolving regulatory frameworks.
  • Pricing Factors: Pricing is influenced by competition, regulatory changes, patent status, and technological innovations.
  • Specific Analysis: Precise price projections require identifying the associated drug and analyzing its specific market context.

FAQs

1. What is the purpose of an NDC in the pharmaceutical industry? An NDC is used to identify the labeler, product, and package size of a medication, ensuring accurate tracking, inventory management, and reimbursement[1][5].

2. How do regulatory changes impact pharmaceutical pricing? Regulatory changes can affect pricing by altering how drugs are tracked, listed, and reimbursed. For example, the Drug Supply Chain Security Act has enhanced drug tracking and security measures[4].

3. What are the key drivers of growth in the biopharma and biotech industries? Key drivers include technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care and precision medicine[3].

4. How does the entry of generics affect pharmaceutical pricing? The entry of generics typically leads to a significant decrease in prices, often by 50% to 70%, as seen with drugs in the NSCLC market[4].

5. What role do technological advancements play in drug development and pricing? Technological advancements, such as AI and machine learning, can lead to more efficient drug development, potentially reducing costs and influencing pricing[3].

Highlight

"Pharma companies are investing heavily in data and AI to foster innovation and reduce drug development costs and timelines, with 85% of biopharma executives saying they plan to invest in data, digital and AI in R&D for 2025"[3].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest drug prices and trends for NDC 00071-0350 - DrugPatentWatch
  3. Exploring 2025 pharma industry trends, outlook and strategies - ZS
  4. Latest drug prices and trends for NDC 51407-0013 - DrugPatentWatch
  5. Drug Name and National Drug Code (NDC) Reference Data Instructions - CMS

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.